Gossamer Bio (GOSS) FCF Margin (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly FCF Margin of 228.38% for Q1 2026, up 17359.0% year-over-year from N/an in Q1 2025, and up 34.77% quarter-over-quarter from 350.13% in Q4 2025.
Gossamer Bio (GOSS) FCF Margin (2024 - 2026) Analysis & Trends
Gossamer Bio's FCF Margin history runs 3 years deep, the most recent figure standing at 228.38% for Q1 2026.
- In Q1 2026, FCF Margin rose 17359.0% year-over-year to 228.38%; the TTM figure through Mar 2026 stood at 306.67% (down 31570.0% YoY), while the FY2025 annual figure was 353.5%, down 34968.0% from the prior year.
- FCF Margin for Q1 2026 stood at 228.38%, up from 350.13% in the prior quarter.
- The five-year high for FCF Margin was 242.65% in Q4 2024, with the low at 410.08% in Q2 2025.
- The 3-year median for FCF Margin is 304.98% (2024), against an average of 204.56%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin sank 59278 bps in 2025, then soared 17359 bps in 2026.
- Gossamer Bio's FCF Margin stood at 242.65% in 2024, then sank by 244 bps to 350.13% in 2025, then soared by 35 bps to 228.38% in 2026.
- Business Quant data shows GOSS's FCF Margin at 228.38% in Q1 2026, 350.13% in Q4 2025, and 272.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | -426.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -426.76% |
| Mar 31, 2026 | -228.38% |
| Dec 31, 2025 | -350.13% |
| Sep 30, 2025 | -272.06% |
| Jun 30, 2025 | -410.08% |
| Mar 31, 2025 | -401.96% |
| Dec 31, 2024 | 242.65% |
| Sep 30, 2024 | -337.90% |
| Jun 30, 2024 | 121.40% |